Shunned by Commercial Markets, Biotechs can Turn to Government Funds

Image: Anne MacNamara Researchers disheartened by the slowdown in private money for genomics projects should keep an eye on the Congressional budget, under debate now. US Government agencies are stepping up their spending on the search for genomic keys to disease. "It's a great time for genomics, as far as we're concerned," says Maria Giovanni, assistant director for microbial genomics and related technology development for the National Institute of Allergy and Infectious Diseases (NIAID). NI

Written byPeg Brickley
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Researchers disheartened by the slowdown in private money for genomics projects should keep an eye on the Congressional budget, under debate now. US Government agencies are stepping up their spending on the search for genomic keys to disease. "It's a great time for genomics, as far as we're concerned," says Maria Giovanni, assistant director for microbial genomics and related technology development for the National Institute of Allergy and Infectious Diseases (NIAID).

NIAID is asking Congress to fund $103.6 million (US) in microbial genome sequencing projects in 2003, more than double the $47.2 million in the current year's budget. The generous government requests follow a withdrawal of venture capital investment. Four deals for genomics companies in 2002 amounted to only $26 million, a 76% decline from the $110 million raised by 10 companies in 2001.

FAME AND FORTUNE The popularity of genomics research accounts for the disparity between public and private ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems